Loading clinical trials...
Loading clinical trials...
A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C
Conditions
Interventions
Daclatasvir
Sofosbuvir
+1 more
Locations
56
Austria
Local Institution
Amstetten, Austria
Local Institution
Braunua/Inn, Austria
Local Institution
Graz, Austria
Local Institution
Innsbruck, Austria
Local Institution
Linz, Austria
Local Institution
Oberndorf, Austria
Last Updated
January 27, 2016
NCT00199719
NCT06922643
NCT03612973
NCT01866930
NCT05895448
NCT02219490
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions